CLPT - ClearPoint Neuro Inc Stock Price, Fair Value and News

$14.06+0.72 (+5.40%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

CLPT Price Action

Last 7 days

-2.6%

Last 30 days

-26%

Last 90 days

26.9%

Trailing 12 Months

17.2%

CLPT RSI Chart

CLPT Valuation

Market Cap

399.6M

Price/Earnings (Trailing)

-17.27

Price/Sales (Trailing)

11.64

EV/EBITDA

-17.66

Price/Free Cashflow

-28.8

CLPT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CLPT Fundamentals

CLPT Revenue

Revenue (TTM)

34.3M

Rev. Growth (Yr)

9.1%

Rev. Growth (Qtr)

-3.84%

CLPT Earnings

Earnings (TTM)

-23.1M

Earnings Growth (Yr)

-18.44%

Earnings Growth (Qtr)

-0.93%

CLPT Profitability

Operating Margin

61.31%

EBT Margin

-66.01%

Return on Equity

-145.77%

Return on Assets

-38.34%

Free Cashflow Yield

-3.47%

CLPT Investor Care

Shares Dilution (1Y)

3.04%

Diluted EPS (TTM)

-0.84

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	32.2M	33.6M	34.3M	0
2024	26.2M	28.1M	30.4M	31.4M
2023	21.0M	21.7M	22.3M	24.0M
2022	17.3M	19.1M	19.7M	20.6M
2021	13.7M	14.7M	15.7M	16.3M
2020	11.9M	11.7M	12.3M	12.8M
2019	8.2M	9.2M	10.3M	11.2M
2018	7.0M	6.7M	6.8M	7.4M
2017	6.4M	7.2M	7.3M	7.4M
2016	3.7M	4.4M	5.1M	5.7M
2015	2.8M	1.7M	2.3M	3.0M
2014	3.5M	4.1M	3.8M	2.6M
2013	5.3M	4.8M	4.6M	3.9M
2012	4.0M	4.4M	4.4M	5.1M
2011	3.0M	3.2M	3.5M	3.8M
2010	0	0	0	2.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About ClearPoint Neuro Inc

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain. It has license and collaboration agreements with Clinical Laserthermia Systems AB, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

CEO	Mr. Joseph Michael Burnett
WEBSITE	clearpointneuro.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	108

ClearPoint Neuro Inc Frequently Asked Questions

What is the ticker symbol for ClearPoint Neuro Inc? What does CLPT stand for in stocks?

CLPT is the stock ticker symbol of ClearPoint Neuro Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ClearPoint Neuro Inc (CLPT)?

As of Wed Dec 03 2025, market cap of ClearPoint Neuro Inc is 399.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLPT stock?

You can check CLPT's fair value in chart for subscribers.

Is ClearPoint Neuro Inc a good stock to buy?

The fair value guage provides a quick view whether CLPT is over valued or under valued. Whether ClearPoint Neuro Inc is cheap or expensive depends on the assumptions which impact ClearPoint Neuro Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLPT.

What is ClearPoint Neuro Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, CLPT's PE ratio (Price to Earnings) is -17.27 and Price to Sales (PS) ratio is 11.64. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLPT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on ClearPoint Neuro Inc's stock?

In the past 10 years, ClearPoint Neuro Inc has provided -0.02 (multiply by 100 for percentage) rate of return.